Liang Kae-Woei, Wang Kuo-Yang
Cardiovascular Center, Taichung Veterans General Hospital, No. 1650. Sec. 4, Taiwan Boulevard, Taichung 40705, Taiwan.
Department of Medicine, School of Medicine, National Yang Ming University, No. 155, Sec. 2, Linong St. Taipei 11221, Taiwan.
Eur Heart J Case Rep. 2020 May 3;4(3):1-5. doi: 10.1093/ehjcr/ytaa052. eCollection 2020 Jun.
Intravenous (IV) prostacyclin analogues infusion and balloon atrial septostomy (BAS) are two important treatment options for managing advanced right heart failure in patients with idiopathic pulmonary arterial hypertension (IPAH). References and protocols are rare for dose titrations and transitions between subcutaneous and IV prostacyclin in functional Class IV IPAH patients. Balloon atrial septostomy is rarely done in very few expert centres.
A young female with IPAH who had received maximal medication including subcutaneous prostacyclin analogues injection was admitted due to advanced right heart failure. She received ascites drainage twice. Later, we directly switched the administration route of prostacyclin from subcutaneous to IV at a ratio of 1:1 instantly. Such rapid conversion led her into a state of profound hypotension and drowsy consciousness, which was resolved after escalating IV inotropics and reducing prostacyclin dosage. Five days later, she received BAS under the guidance of intracardiac echocardiography. Her urine output increased and dyspnoea improved gradually. Six months later, clinical worsening happened again with increase of ascites and dyspnoea. She underwent 2nd and 3rd session of graded BAS with relief of symptoms again. She received permanent transition to IV prostacyclin analogues infusions via a peripherally inserted central catheter after three sessions of BAS.
Balloon atrial septostomy is effective in stabilizing the critical right heart failure in IPAH patients but should be intended as a bridge to lung transplant procedure. Transition from subcutaneous to IV prostacyclin is helpful but needs to be titrated in proper aliquots and time intervals to avoid abrupt haemodynamic changes.
静脉注射前列环素类似物和球囊房间隔造口术(BAS)是治疗特发性肺动脉高压(IPAH)患者晚期右心衰竭的两种重要治疗选择。对于IV级功能的IPAH患者,皮下和静脉注射前列环素之间的剂量滴定和转换的参考文献和方案很少见。球囊房间隔造口术仅在极少数专家中心开展。
一名患有IPAH的年轻女性,接受了包括皮下注射前列环素类似物在内的最大剂量药物治疗,因晚期右心衰竭入院。她接受了两次腹水引流。后来,我们立即将前列环素的给药途径从皮下直接转换为静脉注射,比例为1:1。这种快速转换导致她陷入严重低血压和意识模糊状态,在增加静脉注射强心剂和减少前列环素剂量后症状得到缓解。五天后,她在心脏超声心动图引导下接受了BAS。她的尿量增加,呼吸困难逐渐改善。六个月后,临床症状再次恶化,腹水和呼吸困难加重。她接受了第二次和第三次分级BAS,症状再次缓解。在接受三次BAS后,她通过外周静脉穿刺中心静脉置管永久转换为静脉注射前列环素类似物。
球囊房间隔造口术对稳定IPAH患者的严重右心衰竭有效,但应作为肺移植手术的桥梁。从皮下转换为静脉注射前列环素是有帮助的,但需要以适当的剂量和时间间隔进行滴定,以避免突然的血流动力学变化。